Maričić Vrban, Martina
Radovani Trbojević, Barbara
Visentin, David
Ramljak, Katarina
Kirac, Iva
Gaće, Mihaela
Milas, Ivan
Lauc, Gordan
Primorac, Dragan
Gudelj, Ivan
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (101159018)
Article History
Received: 3 September 2025
Accepted: 21 November 2025
First Online: 27 November 2025
Declarations
:
: The study was approved by the Ethics Committee of the University Hospital for Tumors, Sestre milosrdnice Clinical Hospital Center, Zagreb, Croatia. All participants provided written informed consent prior to inclusion in the study. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: GL declares that he is the founder and owner of Genos Glycoscience Research Laboratory, which offers commercial services of glycomic analysis and has several patents in this field. IG and BRT are employees of Genos Glycoscience Research Laboratory. The other authors declare no conflict of interest.